CLINICAL_TRIALS
trial_result
· 2018-04-05
Clinical Trial Update: Reversal of Ketamine Pharmacodynamic Effects With Naloxone [Phase 4]
Summary
A Phase 4 trial investigated whether naloxone can reverse the pharmacodynamic effects of ketamine in pain conditions. The study was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ullevaal University Hospital | Conditions: Pain | Phase 4 | Status: TERMINATED